Policy Statements
Long Term Care (LTC):
The Bureau of Drug Control has adopted a policy similar to many other states that sponsor a monitoring program. The Prescription Monitoring Program’s (PMP) policy is that pharmacies that dispense medications to LTC facility residents do not have to report this population's controlled substance (CII-CIV) dispensing activity. However, if the pharmacy dispenses to non-LTC residents (i.e.: outpatient hospice, outpatient home infusion, pharmacy employees/families or outpatient retail customers) reporting to the PMP must occur.
Zero Reporting: Coming Soon Electronic Submission of “0” Reporting!
The Prescription Monitoring Program’s policy for a dispenser who has a month of dispensing activity of “0”, are required to send the PMP an email or fax stating their dispenser name, location, DEA number, S.C. Controlled Substance number and/or S.C. Non-Resident Permit number, the time frame for which there has been no controlled substance (CII-CIV) dispensed.
Home Infusion:
The Prescription Monitoring Program’s policy is that any pharmacy that dispenses home infusion medications to outpatient hospice and/ or outpatient home infusion patients, must report to the PMP.
Emergency Room / Department Dispensing:
The Prescription Monitoring Program’s policy is that any controlled substance (CII-CIV) dispensing activity, up to a 48-hour supply, in a licensed institutional or hospital emergency room/department does not have to be reported to the PMP. However, if a facility emergency room/department dispenses quantities greater than a 49-hour supply, the dispensing activity must be reported to the PMP.
For additional information, contact:
(803) 896-0688